TERESA STEFFY to Heterocyclic Compounds, 3-Ring
This is a "connection" page, showing publications TERESA STEFFY has written about Heterocyclic Compounds, 3-Ring.
Connection Strength
0.278
-
Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV. AIDS. 2026 May 01; 40(5):600-610.
Score: 0.231
-
Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa. Pediatr Infect Dis J. 2023 07 01; 42(7):576-581.
Score: 0.047